1Diez J,Laviades C,Mayor G.Effects of antihypertensive therapy onleft ventricular hypertrophy of essential hypertension:a role for insulin-like growthfactor I?J Hum Hypertens,1993,7(5):479-484
2Diez J, Laviades C. Insulin-like growth factor-1 and cardiac mass in essentialhypertension: comparative effects of captopril, lisinopril and quinapril. J Hypertens, 1994,12(Suppl4):S31-36
3Diez J,Laviades C.Insulin-like growth factor I and collagen type Ⅲ synthesis inpatients with essential hypertension and left ventricular hypertrophy.J HumHypertens,1994,8(Suppl 1):S21-25
4Maccario M,Oleandri SE,Avogadri E,et al.Effects of 3-month nifedipine treatment onendocrine-metabolic parameters in patients with abdominal obesity and mild hypertension.JEndocrinol Invest,1998,21(1):56-63
5Lemne C,Brismar K.Insulin-like growth factor binding protein-1 as a marker of themetabolic syndrome-a study in borderline hypertension.Blood Press,1998,7(2):89-95
6Verdecchia,P,Reboldi G,Schillaci G,et al.Circulating insulin and insulin growthfactor-1 are independent determinants of left ventricular mass and geometry in essentialhypertension.Circulation,1999,100(17):1802-1807
7Galderisi M,Vitale G,Lupoli G,et al.Inverse association between free insulin-likegrowth factor-1 and isovolumic relaxation in arterial systemichypertension.Hypertension,2001,38(4):840-845
8Jalil JE,Ebensperger R,Melendez J,et al.Effects of antihypertensive treatment oncardiac IGF-1 during prevention of ventricular hypertrophy in the rat.LifeSci,1999,64(18):1603-1612
9Cottone S,Vadala A,Vella MC,et al.Changes of plasma endothelin and growth factorlevels,and of left ventricular mass,after chronic AT1-receptor blockade in humanhypertension.Am J Hypertens,1998,11(5):548-553
10Cottone S,Vella MC,Vadala A,et al.Influence of vascular load on plasmaendothelin-1,cytokines and catecholamine levels in essential hypertensives.BloodPress,1998,7(3):144-148
